Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus
Masayuki Mizui(The University of Osaka), George C. Tsokos(Beth Israel Deaconess Medical Center)
Cited by 71
Related Papers
CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance
|Journal of Clinical Investigation|2014|216
Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation
|JCI Insight|2019|99
Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus
|Proceedings of the National Academy of Sciences|2011|52
Skeletal muscle heme oxygenase-1 activity regulates aerobic capacity
|Cell Reports|2021|41